Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ARL10 mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | decreases expression | ISO | Arl10 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ARL10 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Estradiol results in increased expression of ARL10 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ARL10 gene | CTD | PMID:21212295 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARL10 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Arl10 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARL10 mRNA | CTD | PMID:21570461 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Arl10 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of ARL10 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Arl10 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of ARL10 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Arl10 (Mus musculus) | 6480464 | bisphenol S affects the methylation of ARL10 gene | CTD | PMID:31683443 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ARL10 mRNA | CTD | PMID:22504374 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of ARL10 mRNA | CTD | PMID:24780913 | acrylamide | decreases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of ARL10 mRNA | CTD | PMID:32763439 | antirheumatic drug | increases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of ARL10 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | ARL10 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ARL10 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases methylation | ISO | ARL10 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ARL10 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ARL10 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ARL10 mRNA | CTD | PMID:30816183 and PMID:32528016 | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of ARL10 mRNA | CTD | PMID:23125180 | choline | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARL10 gene | CTD | PMID:20938992 | copper atom | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ARL10 mRNA | CTD | PMID:15467011 | copper(0) | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ARL10 mRNA | CTD | PMID:15467011 | crocidolite asbestos | increases expression | ISO | Arl10 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of ARL10 mRNA | CTD | PMID:19446018 | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of ARL10 mRNA | CTD | PMID:23640034 | dioxygen | increases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of ARL10 mRNA | CTD | PMID:25596134 | dorsomorphin | multiple interactions | ISO | ARL10 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL10 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ARL10 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of ARL10 mRNA | CTD | PMID:29391264 | epoxiconazole | increases expression | ISO | Arl10 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of ARL10 mRNA | CTD | PMID:35436446 | folic acid | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARL10 gene | CTD | PMID:20938992 | formaldehyde | decreases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of ARL10 mRNA | CTD | PMID:27905399 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of ARL10 mRNA | CTD | PMID:33387578 | L-methionine | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARL10 gene | CTD | PMID:20938992 | lipopolysaccharide | multiple interactions | ISO | Arl10 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ARL10 gene | CTD | PMID:21212295 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of ARL10 mRNA | CTD | PMID:22504374 | nickel sulfate | decreases expression | ISO | ARL10 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of ARL10 mRNA | CTD | PMID:22714537 | ozone | multiple interactions | ISO | ARL10 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ARL10 mRNA | CTD | PMID:35430440 | p-chloromercuribenzoic acid | decreases expression | ISO | ARL10 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of ARL10 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | ARL10 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL10 mRNA | CTD | PMID:27188386 | paracetamol | affects expression | ISO | Arl10 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ARL10 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ARL10 mRNA | CTD | PMID:33387578 | pirinixic acid | decreases expression | ISO | Arl10 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of ARL10 mRNA | CTD | PMID:17950772 | SB 431542 | multiple interactions | ISO | ARL10 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARL10 mRNA | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | ARL10 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ARL10 mRNA | CTD | PMID:22714537 | sunitinib | increases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ARL10 mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of ARL10 mRNA | CTD | PMID:33359661 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ARL10 mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ARL10 mRNA | CTD | PMID:31150632 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of ARL10 mRNA | CTD | PMID:23411599 | triclosan | decreases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of ARL10 mRNA | CTD | PMID:30510588 | triptonide | decreases expression | ISO | Arl10 (Mus musculus) | 6480464 | triptonide results in decreased expression of ARL10 mRNA | CTD | PMID:33045310 | trovafloxacin | increases expression | ISO | Arl10 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of ARL10 mRNA | CTD | PMID:35537566 | valproic acid | increases methylation | ISO | ARL10 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ARL10 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | ARL10 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ARL10 mRNA | CTD | PMID:23179753 | |